ProCE Banner Activity

CE / CME

Research Review: A Bold Panoramic Grasp of Tardive Dyskinesia

Multimedia

In this video roundtable activity, Christoph U. Correll, MD; Leslie Citrome, MD, MPH; and Amber Hoberg, PMHNP, discuss recently published articles of interest in tardive dyskinesia care.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Psychologists: 1.00 APA CE Credit

Social Workers: 1.00 ASWB ACE CE Credit

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit 

Released: October 19, 2022

Expiration: October 18, 2023

No longer available for credit.

Share

Faculty

Leslie Citrome

Leslie Citrome, MD, MPH

Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Christoph U. Correll

Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell,
New York, New York
Professor and Chair
Department of Child and Adolescent Psychiatry
Charité University Medicine,
Berlin, Germany

Amber Hoberg

Amber Hoberg, PMHNP

Nurse Practitioner
MorningStar Family Medicine PLLC
Floresville, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Neurocrine Biosciences, Inc.

Teva Pharmaceuticals

Target Audience

This activity is intended for psychiatrists, nurse practitioners, physician associates/physician assistants, nurses, pharmacists, psychologists, and social workers.

Program Learning Goal

The goal of this activity is to improve the knowledge, competence, and performance of healthcare professionals to individualize the therapeutic management of patients with tardive dyskinesia.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe patient insight regarding TD
  • Describe the effective use of VMAT2 inhibitors without needing to modify the remainder of the individual’s medication regimen

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Leslie Citrome, MD, MPH

Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Leslie Citrome, MD, MPH: consultant: AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, INmune Bio, Impel, Intra-Cellular Therapies, Janssen, Karuna, Lundbeck, Lyndra, Medavante-ProPhase, Marvin, Merck, Mitsubishi-Tanabe Pharma, Neurocrine, Neurelis, Novartis, Noven, Otsuka, Ovid, Praxis, Recordati, Relmada, Reviva, Sage, Sunovion, Supernus, Teva, University of Arizona; speaker: AbbVie/Allergan, Acadia, Alkermes, Angelini, Axsome, BioXcel, Eisai, Idorsia, Intra-Cellular Therapies, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Recordati, Sage, Sunovion, Takeda, Teva, Medscape, NACCME, NEI, Vindico; stocks/stock options: Bristol-Myers Squibb, Johnson & Johnson, Lilly, Merck, Pfizer, Reviva.

Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell,
New York, New York
Professor and Chair
Department of Child and Adolescent Psychiatry
Charité University Medicine,
Berlin, Germany

Christoph U. Correll, MD: consultant/advisor: AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Boehringer Ingelheim, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Gedeon Richter, Hikma, Holmusk, Intra-Cellular Therapies, Janssen/Johnson & Johnson, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Newron, Noven, Otsuka, Pharmabrain, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Seqirus, SK Life Science, Sun Pharma, Sunovion, Supernus, Takeda, Teva, Viatris; expert testimony: Janssen, Otsuka; data and safety monitoring board: Lundbeck, Relmada, Reviva, Rovi, Supernus, Teva; grant support: Janssen, Takeda; stock options: Cardio Diagnostics, Mindpax, LB Pharma, Quantic.

Amber Hoberg, PMHNP

Nurse Practitioner
MorningStar Family Medicine PLLC
Floresville, Texas

Amber Hoberg, PMHNP: consultant/advisor/speaker: Acadia, Avanir, BioXcel, Intra-Cellular Therapies, Neurocrine, Teva.

Staff Disclosure

Staff

Stephanie Filice, LICSW

Stephanie Filice, LICSW, has no relevant financial relationships to disclose.

Raquel Gaerlan,

Director, Scientific Services

Raquel Gaerlan has no relevant financial relationships to disclose.

Gabrielle Giacona,

Associate Scientific Director

Gabrielle Giacona: stock/stock options: AstraZeneca, Moderna, Teva.

Lisa Phipps, PharmD, PhD

Director, Science and Strategy, Neuroscience

Lisa Phipps, PharmD, PhD, has no relevant financial relationships to disclose.

Dace Svikis, PhD

Professor
Department of Psychology
Virginia Commonwealth University
Richmond, Virginia

Dace S. Svikis, PhD, has no relevant financial relationships to disclose.

Amanda Zimmerman, PA-C

Physician Assistant
West Forsyth Pain Management
Winston-Salem, North Carolina

Amanda Zimmerman, PA-C: researcher: Biodelivery Sciences International.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-260-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Psychologists

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity offers 1.0 continuing education credit for psychologists.

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 clinical continuing education credits.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for maximum of 1.0 hour of AAPA Category 1 CME credit. Approval is valid until October 17, 2023. PAs should only claim commensurate with the extent of their participation.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 19, 2022, through October 18, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.